Dr. Shah on the Significance of PARP Inhibitors in Ovarian Cancer
Payal D. Shah, MD, discusses the significance of the emergence of PARP inhibitors in ovarian cancer.
Dr Deek on the Investigation of Immune Cell Infiltration in MIBC
Hypofractionated and Conventionally Fractionated Radiotherapy Generate Similar QOL, Safety in Breast Cancer
Dr Hoppe on the Rationale for the CheckMate 744 Trial in Hodgkin Lymphoma
Dr Chuong on the Patterns of Guided Radiation Therapy in Pancreatic Cancer
2 Clarke Drive Cranbury, NJ 08512